148. Deputy Colm Burke asked the Minister for Health if his Department and the HSE will review the decision not to allow for reimbursement of cannabidiol, epidiolex in view of the fact that there has been clear evidence to show that this drug is extremely effective in the management of care for patients with dravet syndrome and lennox-gastaut syndrome; and if he will make a statement on the matter. [48542/21]

Summary

148. Deputy Colm Burke asked the Minister for Health if his Department and the HSE will review the decision not to allow for reimbursement of cannabidiol, epidiolex in view of the fact that there has been clear evidence to show that this drug is extremely effective in the management of care for patients with dravet syndrome and lennox-gastaut syndrome; and if he will make a statement on the matter. [48542/21]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 6 October 2021

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.